An open-label single-center investigator-initiated exploratory clinical study in patients with refractory or recurrent solid tumors using SBRT as “in situ vaccination”: R-ISV-FOLactis trial. This is ...
Medical Device Network on MSN
Countable Labs raises $26M for PCR technology advancement
Countable Labs claims that its Countable PCR technology is “at least 10 times” more sensitive than conventional PCR.
Designing reproducible PCR assays involves optimizing multiple moving targets, from standardizing each component in sometimes minute reaction volumes to planning ahead to ensure long-term and secure ...
Simplify and accelerate the creation of your lyophilized amplification assay to expedite the development of your point-of-care application. Promega has dedicated time to perfecting reagent ...
GlobalData on MSN
Roche develops RUO PCR assay to detect rare Ebola Bundibugyo virus
TIB MOLBIOL developed the test using its "rapid response" library, with 15,000 designs and 3,000 controls.
Human papillomavirus (HPV) is a DNA virus known to cause infections in mucous membranes and skin, typically resulting in warty lesions. While often benign, these lesions do have the potential to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results